Faced with thousands of listed company announcements every day, which ones should you read? Key announcements are often dozens or even hundreds of pages long—what are the highlights? Full of technical jargon, do you know whether an announcement is positive or negative news? Please refer to the ‘Quick Read Announcement’ column by Cailian News’ Company News Department. Our reporters stationed nationwide will provide you with accurate, fast, and professional interpretations of announcements on the same evening they are released.

Cailian Press reported on March 10 (by reporter Wu Chao) that the trend of A-share companies going public in Hong Kong continues to rise. This evening, three A-share companies—Changying Precision (300115.SZ), Huasheng Lithium Battery (688353.SH), and VeriSilicon (688521.SH)—issued announcements declaring their plans to issue H-shares, further expanding this year’s “A+H” wave. Meanwhile, following the listings of Estun (002747.SZ) and Zhaowei Electromechanical (003021.SZ) on the Hong Kong Stock Exchange yesterday, Meig Smart (002881.SZ) became the third A-share company this month to complete a dual listing on both the A-share and H-share markets.

Changying Precision, which specializes in consumer electronics and new energy components, issued a notice today stating that it is planning an overseas share issuance (H-shares) and aims to list on the Main Board of the Hong Kong Stock Exchange. The announcement stated that this move aims to advance the company’s international strategic layout, create a diversified capital operation platform, and enhance its international brand image and global market competitiveness. As of the date of the announcement, Changying Precision is discussing the relevant work for this issuance and listing with intermediaries, but specific details have not yet been finalized.

Huasheng Lithium Battery, a company specializing in electrolyte additives, also announced today that its board of directors has convened and passed a resolution to issue H-shares and list them on the Main Board of the Hong Kong Stock Exchange. Similar to Changying Precision, Huasheng Lithium Battery stated that this move is intended to meet the needs of the company’s international strategy and overseas business layout, enhance its international brand recognition, and strengthen its overall competitiveness. Additionally, Huasheng Lithium Battery adjusted several management systems, including its articles of association, information disclosure management system, and shareholders’ meeting rules, to align with requirements after the H-share issuance and listing.

VeriSilicon, a company providing chip customization services and semiconductor IP licensing, disclosed similar plans. The announcement stated that, to meet the company’s business development needs, continuously attract and gather top R&D and management talent, further promote its international strategy, and create an international capital operation platform, thereby enhancing the company’s capital strength, it intends to issue overseas-listed shares (H-shares) and list them on the Hong Kong Stock Exchange. VeriSilicon stated that it will fully consider the interests of existing shareholders and the conditions of domestic and international capital markets, choosing an appropriate timing and issuance window to complete this offering within the validity period of the shareholder resolution (i.e., within 24 months from the date of the shareholder meeting approval) or any other extended period agreed by the shareholders.

Meig Smart, an IoT module manufacturer, officially went public on the Hong Kong Stock Exchange today, with 40.25 million H-shares (03268.HK) listed and traded on the Main Board. According to the announcement, Meig Smart’s H-shares were immediately included in the list of securities eligible for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs as of the first day of listing, providing mainland investors with a convenient investment channel. From the issuance results, Meig Smart’s final offer price was set at HKD 28.86, representing a discount compared to its previous A-share closing price. The net proceeds from the offering amounted to approximately HKD 1.091 billion, which will be primarily used to enhance R&D innovation capabilities, expand overseas sales networks, and make strategic investments. At the close of trading, the stock closed at HKD 29.30, up 1.5%, with the lowest price reaching HKD 28.42 during intraday trading when it briefly fell below the issue price.

Notably, Estun Automation, a leading industrial robotics company, debuted on the Hong Kong Stock Exchange yesterday, closing at HKD 12.90 per share, down 16.02%, and broke below the issue price on its first day of trading. According to available data, since the beginning of 2026, a total of 28 new stocks have been listed on the Hong Kong Stock Exchange, with most experiencing rising share prices on their first trading day. Estun Automation and Meig Smart are among the few new listings that encountered price declines after opening.

The developments involving multiple companies today reflect only a snapshot of the continued surge in “A+H” listings since the start of 2026. According to Wind data statistics, from January 1 to March 10, 2026, 13 A-share companies have successfully listed H-shares on the Hong Kong Stock Exchange, including industry leaders such as Muyuan Foods and Dongpeng Beverage, whose initial public offerings raised over HKD 10 billion each. By comparison, in 2024 and 2025, the number of A-share companies listing on the Hong Kong market was 3 and 19, respectively. In terms of applications or planning, 44 A-share companies have undergone Hong Kong Stock Exchange hearings this year. Additionally, from an industry perspective, this wave of “Hong Kong fever” differs significantly from earlier H-share companies, which were predominantly in finance and energy. Currently, companies rushing to list in Hong Kong are highly concentrated in strategic emerging industries such as semiconductors, artificial intelligence, new energy, and biomedicine.